A QMED article cites data from ECRI, the Plymouth Meeting healthcare safety nonprofit, warning about a pervasive medical risk. QMED’s publication, MD+DI, had…

Conshohocken-based Madrigal Pharmaceuticals saw its shares leap in value after the company reported additional positive late-stage clinical trial data for its experimental non…

Collegeville resident Prem Ganesh, a senior bioengineering student at Temple, is back in on campus now. But he’s brought a summer’s worth of…

Philanthropists Susan and Steve Kelly, longtime supporters of the Children’s Hospital of Philadelphia (CHOP), are helping establish the Susan S. and Stephen P. Kelly…

The new analytical testing services laboratory opened by the Center for Breakthrough Medicines at the Discovery Labs complex in King of Prussia aims to address…

The CEO of a Radnor-based pharmaceutical company, Dr. Scott Braunstein, M.D., has made a top 25 list of Biotech CEOs for 2022, compiled…

The experimental COVID-19 pill developed by Merck, the pharmaceutical giant with sizable operations in West Point, and its partner Ridgeback Biotherapeutics, is less effective…

A new study by the Centers for Disease Control and Prevention (CDC) found the Pfizer COVID-19 vaccine to be 93 percent effective in protecting…

A COVID-19 pill created by Merck, the pharmaceutical giant with sizable operations in West Point, and Ridgeback Biotherapeutics performed well in a key study…

Several local universities are starting to enact vaccination policies for students and staff, before they can be on campus in the fall, writes Pete Bannan…

Merck, the pharmaceutical giant with sizable operations in West Point, has received another approval for its blockbuster cancer antibody Keytruda, writes Mark Terry for BioSpace…

Plymouth Meeting-based Inovio Pharmaceuticals saw its stock drop by 25 percent last week. This was after the U.S. government decided to pull its…

Merck, the pharmaceutical giant with sizable operations in West Point, has decided to discontinue the development of the experimental COVID-19 drug it acquired from…

Plymouth Meeting-based Inovio saw its stock jump after signing a collaboration and license agreement with Advaccine Biopharmaceuticals Suzhou for its COVID-19 DNA vaccine…

Blue Bell-based Pinnacle 21 is seeing demand for its services grow as companies rush to get new drugs and vaccines on the market due…

Plymouth Meeting-based Inovio Pharmaceuticals is waiting for approval from the FDA to start the next stage of trials for its COVID-19 vaccine candidate…